{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for beta root_notes_note in Note (approximate match)
Status:
Investigational
Source:
INN:gletimbetasin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tazlestobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:nasaruplase gamma [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:infliximab beta [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03472027: Phase 1 Interventional Completed Melanoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sovipostobart beta [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pegdarbepoetin beta [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sampeginterferon beta-1a [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03578029: Phase 2 Interventional Terminated Junctional Epidermolysis Bullosa
(2019)
Source URL:
Class:
PROTEIN